Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Assets (2020 - 2025)

Historic Assets for HCW Biologics (HCWB) over the last 6 years, with Q3 2025 value amounting to $25.4 million.

  • HCW Biologics' Assets fell 418.33% to $25.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.4 million, marking a year-over-year decrease of 418.33%. This contributed to the annual value of $30.2 million for FY2024, which is 604.24% up from last year.
  • Per HCW Biologics' latest filing, its Assets stood at $25.4 million for Q3 2025, which was down 418.33% from $28.9 million recorded in Q2 2025.
  • Over the past 5 years, HCW Biologics' Assets peaked at $56.4 million during Q3 2021, and registered a low of $13.0 million during Q2 2021.
  • In the last 5 years, HCW Biologics' Assets had a median value of $33.0 million in 2023 and averaged $36.7 million.
  • As far as peak fluctuations go, HCW Biologics' Assets soared by 26374.58% in 2022, and later tumbled by 3908.53% in 2023.
  • Over the past 5 years, HCW Biologics' Assets (Quarter) stood at $53.5 million in 2021, then decreased by 12.53% to $46.8 million in 2022, then crashed by 39.09% to $28.5 million in 2023, then rose by 6.04% to $30.2 million in 2024, then dropped by 15.85% to $25.4 million in 2025.
  • Its Assets was $25.4 million in Q3 2025, compared to $28.9 million in Q2 2025 and $26.3 million in Q1 2025.